HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).

Adult T-cell leukemia/lymphoma HTLV-1 associated myelopathy/tropical spastic paraparesis Human T-lymphotropic virus type 1 Pathogenesis Systems virology

Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
23 Mar 2021
Historique:
received: 09 12 2020
accepted: 11 03 2021
entrez: 24 3 2021
pubmed: 25 3 2021
medline: 15 5 2021
Statut: epublish

Résumé

Human T cell leukemia virus-1 (HTLV-1) infection may lead to one or both diseases including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) or adult T cell leukemia lymphoma (ATLL). The complete interactions of the virus with host cells in both diseases is yet to be determined. This study aims to construct an interaction network for distinct signaling pathways in these diseases based on finding differentially expressed genes (DEGs) between HAM/TSP and ATLL. We identified 57 hub genes with higher criteria scores in the primary protein-protein interaction network (PPIN). The ontology-based enrichment analysis revealed following important terms: positive regulation of transcription from RNA polymerase II promoter, positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle and positive regulation of transcription from RNA polymerase II promoter by histone modification. The upregulated genes TNF, PIK3R1, HGF, NFKBIA, CTNNB1, ESR1, SMAD2, PPARG and downregulated genes VEGFA, TLR2, STAT3, TLR4, TP53, CHUK, SERPINE1, CREB1 and BRCA1 were commonly observed in all the three enriched terms in HAM/TSP vs. ATLL. The constructed interaction network was then visualized inside a mirrored map of signaling pathways for ATLL and HAM/TSP, so that the functions of hub genes were specified in both diseases.

Identifiants

pubmed: 33757561
doi: 10.1186/s13104-021-05521-y
pii: 10.1186/s13104-021-05521-y
pmc: PMC7989087
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109

Références

Neoplasia. 2004 May-Jun;6(3):266-78
pubmed: 15153339
J Cell Physiol. 2015 Sep;230(9):2240-51
pubmed: 25754990
Front Microbiol. 2016 Nov 07;7:1688
pubmed: 27872612
Cancer Lett. 2006 Mar 28;234(2):249-55
pubmed: 15896902
Cell Signal. 2011 Feb;23(2):425-35
pubmed: 20955790
Int J Cancer. 2009 Dec 15;125(12):2863-70
pubmed: 19609947
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3845-50
pubmed: 9520455
Nat Rev Cancer. 2009 Feb;9(2):95-107
pubmed: 19165225
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Cancer Res. 2000 Jan 15;60(2):417-24
pubmed: 10667596
Lab Invest. 2001 Mar;81(3):349-60
pubmed: 11310828
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189
Oncogene. 2000 Nov 20;19(49):5636-42
pubmed: 11114744
Genes Dev. 2002 Oct 15;16(20):2583-92
pubmed: 12381658
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
J Virol. 2008 Oct;82(19):9359-68
pubmed: 18653454
Annu Rev Immunol. 2018 Apr 26;36:43-71
pubmed: 29144838
Arch Virol. 2017 Apr;162(4):1009-1015
pubmed: 28110427
Curr Opin Virol. 2015 Oct;14:93-100
pubmed: 26414684
J Biol Chem. 2008 Jul 11;283(28):19570-80
pubmed: 18469003
J Cell Biochem. 2018 May;119(5):3968-3979
pubmed: 29227540
Mol Cell Biol. 2001 Apr;21(8):2650-8
pubmed: 11283245
Curr Opin Immunol. 2004 Feb;16(1):67-75
pubmed: 14734112
Cancer Gene Ther. 2006 Feb;13(2):115-24
pubmed: 16138117
J Biol Chem. 2014 Nov 7;289(45):31349-60
pubmed: 25231981
Clin Cancer Res. 2015 Apr 15;21(8):1789-94
pubmed: 25477533
J Biol Chem. 2005 Feb 25;280(8):7010-21
pubmed: 15591054
Sci Rep. 2016 Apr 14;6:24552
pubmed: 27076368
J Biol Chem. 2004 Jul 30;279(31):33024-34
pubmed: 15166238
Cytokine. 2017 Oct;98:42-50
pubmed: 28579221
Oncogene. 2005 Sep 5;24(39):5976-85
pubmed: 16155604
Biochim Biophys Acta Gene Regul Mech. 2017 Apr;1860(4):502-515
pubmed: 28153703
Mol Cell Biol. 1992 Sep;12(9):3784-95
pubmed: 1508184
Bioinformatics. 2006 Dec 15;22(24):3106-8
pubmed: 17060356
Sci Rep. 2017 Mar 08;7:43834
pubmed: 28272417
EMBO J. 2000 Jul 3;19(13):3325-36
pubmed: 10880445
FEBS Lett. 1990 May 7;264(1):75-7
pubmed: 2186928
Cell. 2009 Apr 3;137(1):87-98
pubmed: 19345189
Nat Rev Dis Primers. 2015 Jun 18;1:15012
pubmed: 27188208
J Biol Chem. 2016 Mar 4;291(10):5068-79
pubmed: 26792858

Auteurs

Mohadeseh Zarei-Ghobadi (M)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Mohsen Sheikhi (M)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Majid Teymoori-Rad (M)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Sahar Yaslianifard (S)

Department of Biochemistry, Faculty of Life Sciences of Islamic, Azad University, Tehran north branch, Tehran, Iran.

Mehdi Norouzi (M)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.

Somayeh Yaslianifard (S)

Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran.

Reza Faraji (R)

Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.

Mohammad Farahmand (M)

Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.

Shiva Bayat (S)

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Mohieddin Jafari (M)

Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Sayed-Hamidreza Mozhgani (SH)

Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran. hamidrezamozhgani@gmail.com.
Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. hamidrezamozhgani@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH